Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

BBIOBBIO
29 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in BRIDGEBIO PHARMA INC

VIKING GLOBAL INVESTORS LP holds 9.9M shares of BBIO (BRIDGEBIO PHARMA INC), worth $741M as of 2026-Q2. The position was decreased (-16.0% shares). BBIO represents 2.1% of VIKING GLOBAL INVESTORS LP's portfolio.

Current Value

$741M

Current Shares

9.9M

Total Value Change

+$23M

Total Shares Change

-16.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
9.9M
-16.0%
$741M2.1%$74.48
0
2026-Q1
Decreased
11.8M
-17.7%
$879.4M2.5%$74.26
0
2025-Q4
Decreased
14.4M
-9.9%
$1.1B2.9%$76.49
0
2025-Q3
Decreased
16M
-13.9%
$829.9M2.2%$51.94
0
2025-Q2
Decreased
18.6M
-15.9%
$801.2M2.3%$43.18
0
2025-Q1
Decreased
22.1M
-12.2%
$762.5M2.4%$34.57
0
2024-Q4
Unchanged
25.1M
0.0%
$689.3M2.2%$27.44
0
2024-Q3
Unchanged
25.1M
0.0%
$639.6M2.3%$25.46
0
2024-Q2
Unchanged
25.1M
0.0%
$636.3M2.4%$25.33
0
2024-Q1
Unchanged
25.1M
0.0%
$776.7M2.9%$30.92
0
2023-Q4
Unchanged
25.1M
0.0%
$1B3.7%$40.37
0
2023-Q3
Decreased
25.1M
-5.6%
$662.4M2.7%$26.37
0
2023-Q2
Unchanged
26.6M
0.0%
$457.9M1.9%$17.20
0
2023-Q1
Unchanged
26.6M
0.0%
$441.4M2.1%$16.58
0
2022-Q4
Unchanged
26.6M
0.0%
$202.9M1.0%$7.62
0
2022-Q3
Unchanged
26.6M
0.0%
$264.6M1.2%$9.94
0
2022-Q2
Unchanged
26.6M
0.0%
$241.7M1.1%$9.08
0
2022-Q1
Unchanged
26.6M
0.0%
$270.2M1.1%$10.15
0
2021-Q4
Unchanged
26.6M
0.0%
$444M1.3%$16.68
0
2021-Q3
Unchanged
26.6M
0.0%
$1.2B3.4%$46.87
0
2021-Q2
Unchanged
26.6M
0.0%
$1.6B4.9%$60.96
0
2021-Q1
Unchanged
26.6M
0.0%
$1.6B4.9%$61.60
0
2020-Q4
Unchanged
26.6M
0.0%
$1.9B5.2%$71.11
0
2020-Q3
Unchanged
26.6M
0.0%
$998.8M3.6%$37.52
0
2020-Q2
Unchanged
26.6M
0.0%
$868.1M3.8%$32.61
0
2020-Q1
Unchanged
26.6M
0.0%
$772M4.0%$29.00
0
2019-Q4
Unchanged
26.6M
0.0%
$933.1M4.4%$35.05
0
2019-Q3
Unchanged
26.6M
0.0%
$571.6M3.0%$21.47
0
2019-Q2
New
26.6M
-
$718M3.2%$26.97
88

Other major holders of BBIO: VANGUARD GROUP INC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used